Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
暂无分享，去创建一个
S. Lippman | I. Wistuba | J. Erasmus | H. Tran | B. Bekele | F. Johnson | G. Blumenschein | N. Takebe | D. Stewart | L. Hwang | X. Tang | Lei Feng | Jeremy J. Erasmus | Faye M. Johnson | B. Nebiyou Bekele | Xi Ming Tang | David J. Stewart | X. M. Tang